Old Mission Capital’s AtriCure ATRC Stock Holding History

Old Mission Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,236	Closed	-$1.69M	–	1354
2021 Q4	$1.69M	Buy	+24,236	New	+$1.76M	0.07%	283

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Old Mission Capital's ATRC Position: Q1 2022 in Review

Old Mission Capital sold out of AtriCure (ATRC) in Q1 2022, closing a stake of 24,236 shares — an estimated $1.69M sold.

Old Mission Capital first reported a position in ATRC in Q4 2021 and held it in 1 quarter. The position peaked at $1.69M in Q4 2021. 217 funds tracked by Wall St. Rank hold ATRC as of Q1 2022.

Old Mission Capital reported no remaining AtriCure position as of Q1 2022 after selling out during the quarter.
Old Mission Capital sold 24,236 AtriCure shares in Q1 2022, an estimated $1.69M.
Old Mission Capital first reported a position in AtriCure in Q4 2021 and held it in 1 quarter.
Old Mission Capital's AtriCure position peaked at $1.69M in Q4 2021.
217 funds tracked by Wall St. Rank held AtriCure as of Q1 2022.

Based on Old Mission Capital's 13F filing for Q1 2022, filed 13 May 2022.